First Manhattan CO Natera, Inc. Transaction History

First Manhattan CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 16, 2019	SELL	$17.75 - $27.58 $18.2 Million - $28.3 Million	-1,027,242 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$11.34 - $20.62 $5.79 Million - $10.5 Million	510,509 Added 98.8%	1,027,242 $21.2 Million
Q4 2018 Jan 30, 2019	BUY	$12.32 - $24.38 $3.37 Million - $6.66 Million	273,300 Added 112.27%	516,733 $7.21 Million
Q3 2018 Oct 15, 2018	SELL	$18.82 - $28.96 $4.05 Million - $6.23 Million	-215,200 Reduced 46.92%	243,433 $5.83 Million
Q1 2018 Apr 20, 2018	BUY	$9.0 - $11.95 $3.24 Million - $4.3 Million	360,133 Added 365.62%	458,633 $4.25 Million
Q4 2017 Jan 22, 2018	BUY	$8.99 - $14.31 $885,515 - $1.41 Million	98,500	98,500 $885,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.